Renal Toxicity of Rosuvastatin: A Case Report

瑞舒伐他汀肾毒性:病例报告

阅读:1

Abstract

This is a report of a 64-year-old man who developed acute kidney injury (AKI) associated with high-dose rosuvastatin. He had been treated with statins for several years due to coronary artery disease, hypertension, and hyperlipidemia. He had initially been treated with simvastatin, though it was changed to rosuvastatin for stronger effects on cholesterol and cardiovascular risk reduction. About 12 months after getting rosuvastatin 40 mg per day, AKI was detected. Though other factors were likely contributing, the AKI appeared to be nephrotoxic in nature. There were two medications on his list, rosuvastatin and pantoprazole, which plausibly could cause reduced kidney function, and we discussed a trial of medication withdrawal. He had severe esophageal disease, which was at risk of a flare with coming off the pantoprazole, so we elected to stop rosuvastatin first. After stopping rosuvastatin, the kidney function returned to baseline, and the abnormal urine testing resolved.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。